FluMist approved for self-administration in the US - astrazeneca.com
Sep 20, 2024 · FluMist has been approved in the US as the only self-administered influenza vaccine. FluMist, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or administered by a parent/caregiver to individuals 2-17 years of age. 1
FluMist approved for self-administration in the US
Sep 20, 2024 · Only influenza vaccine approved for self- or caregiver-administration at home, expanding options for influenza protection. WILMINGTON, Del., September 20, 2024 – FLUMIST ® has been approved in the US as the only self-administered influenza vaccine.
FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver ...
Sep 20, 2024 · FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age. FluMist is sprayed into the nose and has been...
FDA approves first flu vaccine that can be self-administered at …
Sep 20, 2024 · CNN — The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this...
FLUMIST® QUADRIVALENT (Influenza Vaccine Live ... - AstraZeneca US
Sep 23, 2022 · AstraZeneca announces FLUMIST ® QUADRIVALENT (Influenza Vaccine Live, Intranasal) doses are now available in the US for the 2022-2023 influenza season. FLUMIST QUADRIVALENT, the only Food and Drug Administration (FDA)-approved nasal-spray flu vaccine, is indicated for people ages 2 through 49. 1.
US FDA approves AstraZeneca's self-administered nasal spray flu …
Sep 20, 2024 · The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for self-administration, making it the first of its kind.
Maker of FluMist seeks to allow at-home administration of …
Oct 24, 2023 · AstraZeneca, which makes the vaccine FluMist, announced Tuesday it has submitted to the Food and Drug Administration a supplemental biologics license application that would allow for...
Next season, you may be able to take your flu vaccine at home
Oct 24, 2023 · The US Food and Drug Administration is reviewing an application for the nasal spray flu vaccine FluMist to be able to be self-administered at home, drugmaker AstraZeneca said Tuesday. The...
Nasal Flu Vaccine FluMist Gets FDA Approval for At-Home Use
Oct 4, 2024 · Recently, the Food and Drug Administration (FDA) removed those obstacles by approving the at-home use of FluMist®, an influenza vaccine administered by nasal spray. Made by AstraZeneca, FluMist will be available for home use starting in the fall of 2025.
US Food and Drug Administration accepts for review AstraZeneca…
Oct 24, 2023 · AstraZeneca’s Supplemental Biologics License Application (sBLA) for the approval of a self- or caregiver-administered option for FluMist Quadrivalent, a needle-free nasal spray, has been accepted for review by the US Food and Drug Administration (FDA).